| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SMPD2 |
| Uniprot No | O60906 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-423aa |
| 氨基酸序列 | MKPNFSLRLRIFNLNCWGIPYLSKHRADRMRRLGDFLNQESFDLALLEEVWSEQDFQYLRQKLSPTYPAAHHFRSGIIGSGLCVFSKHPIQELTQHIYTLNGYPYMIHHGDWFSGKAVGLLVLHLSGMVLNAYVTHLHAEYNRQKDIYLAHRVAQAWELAQFIHHTSKKADVVLLCGDLNMHPEDLGCCLLKEWTGLHDAYLETRDFKGSEEGNTMVPKNCYVSQQELKPFPFGVRIDYVLYKAVSGFYISCKSFETTTGFDPHRGTPLSDHEALMATLFVRHSPPQQNPSSTHGPAERSPLMCVLKEAWTELGLGMAQARWWATFASYVIGLGLLLLALLCVLAAGGGAGEAAILLWTPSVGLVLWAGAFYLFHVQEVNGLYRAQAELQHVLGRAREAQDLGPEPQPALLLGQQEGDRTKEQ |
| 预测分子量 | 49.1 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SMPD2重组蛋白的3篇参考文献及其摘要概括：
---
1. **文献名称**：*Recombinant human neutral sphingomyelinase 2 (nSMase2): purification, kinetic analysis, and inhibitor screening*
**作者**：Horner et al.
**摘要**：该研究报道了人源SMPD2(nSMase2)重组蛋白在大肠杆菌中的表达与纯化，分析了其酶动力学特性(如最适pH、金属离子依赖性)，并利用重组蛋白筛选了潜在抑制剂，为靶向SMPD2的药物开发提供基础。
2. **文献名称**：*Structural insights into the catalytic mechanism of SMPD2 through cryo-EM analysis*
**作者**：Zhang et al.
**摘要**：通过冷冻电镜解析了重组SMPD2蛋白的三维结构，揭示了其底物结合口袋和催化关键残基，阐明了该酶水解鞘磷脂的分子机制，为设计特异性调控分子奠定结构基础。
3. **文献名称**：*Role of recombinant SMPD2 in exosome-mediated cellular communication*
**作者**：Clarke et al.
**摘要**：研究发现重组SMPD2可通过调控神经酰胺生成，促进外泌体分泌，揭示其在细胞间信号传递中的作用，并利用重组蛋白验证了其在肿瘤微环境中的功能。
---
**备注**：以上文献为示例性概括，实际引用时需核对具体文献信息。建议通过PubMed或Google Scholar以“SMPD2 recombinant protein”“nSMase2 expression”等关键词检索最新研究。
**Background of SMPD2 Recombinant Protein**
SMPD2 (sphingomyelin phosphodiesterase 2), also known as neutral sphingomyelinase 2 (nSMase2), is a key enzyme in sphingolipid metabolism. It catalyzes the hydrolysis of sphingomyelin to produce ceramide and phosphocholine, regulating critical cellular processes such as membrane homeostasis, signal transduction, and stress responses. Unlike its acidic counterpart SMPD1. SMPD2 operates optimally at neutral pH and is localized to the plasma membrane or secreted via extracellular vesicles, influencing intercellular communication.
Recombinant SMPD2 protein is engineered using expression systems like *E. coli* or mammalian cells to ensure proper folding and enzymatic activity. Its structure includes a catalytic domain essential for sphingomyelin cleavage and regulatory regions that modulate activity under physiological conditions (e.g., calcium or phosphatidylserine binding). Recombinant forms enable precise study of SMPD2’s role in diseases, including cancer, neurodegenerative disorders (e.g., Alzheimer’s), and metabolic syndromes, where dysregulated ceramide levels contribute to pathogenesis.
Research applications include *in vitro* enzyme activity assays, drug screening for SMase inhibitors/activators, and mechanistic studies of SMPD2-linked pathways. For instance, SMPD2-derived ceramide regulates exosome release, apoptosis, and inflammatory responses, making it a therapeutic target. Recombinant SMPD2 also aids in exploring its crosstalk with other sphingolipid enzymes (e.g., ceramidases) and validating biomarkers for disease progression. Overall, SMPD2 recombinant protein serves as a vital tool for unraveling sphingolipid biology and developing targeted therapies.
×
